In addition, studies based on the brain tissue of AD patients have shown an upregulation of miRNA-146a, which targets and downregulates complement factor H (CFH), interleukin-1 receptor-associated kinase-1 (IRAK-1) and tetraspanin-12 (TSPAN12). This evidence concerns the gene IRAK1 and Alzheimer disease.